T 0341/09 (Antibody/WELLCOME) of 05.10.2011
- European Case Law Identifier
- ECLI:EP:BA:2011:T034109.20111005
- Date of decision
- 5 October 2011
- Case number
- T 0341/09
- Petition for review of
- -
- Application number
- 02076251.4
- IPC class
- C12N 15/13
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Antibody for use in therapy
- Applicant name
- THE WELLCOME FOUNDATION LIMITED
- Opponent name
- Medimmune Limited
Amgen, Inc
AstraZeneca AB
Bayer Pharma Aktiengesellschaft
Merck Serono SA
Biovitrum AB / Symphogen A/S
Bioinvent International AB
Genentech, Inc.
Boehringer Ingelheim Pharma GmbH & Co KG
Novartis AG
Abbott Laboratories
Wyeth
Genmab A/S - Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 76(1)
- Keywords
- Main request: added matter (yes)
Auxiliary request: added matter (yes) - Catchword
- -
- Cited cases
- T 0461/05
- Citing cases
- -
ORDER
For these reasons it is decided that:
The appeal is dismissed.